Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REGORAFENIB vs REMDESIVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REGORAFENIB vs REMDESIVIR: Safety Overview

Metric REGORAFENIB REMDESIVIR
Total FAERS Reports 9,441 10,501
Deaths Reported 1,869 2,729
Death Rate 19.8% 26.0%
Hospitalizations 3,363 2,556
Average Patient Age 62.2 yrs 61.7 yrs
% Female Patients 39.9% 39.8%
FDA Approval Date Jan 13, 2025 Oct 22, 2020
Manufacturer Bayer HealthCare Pharmaceuticals Inc. Gilead Sciences, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription